MCL1 and neoplasm: When CSC is exposed to chemotherapeutic agents in vivo, some special regulatory mechanisms will be activated; pi3-K, MAPK and other pathways will be cascade-activated, and then the anti-apoptotic protein myeloid cell leukemia-1 (McL-1) will increase to inhibit the apoptosis of tumor cells (22).